LUNESTA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lunesta, and when can generic versions of Lunesta launch?
Lunesta is a drug marketed by Woodward and is included in one NDA.
The generic ingredient in LUNESTA is eszopiclone. There are twenty drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the eszopiclone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lunesta
A generic version of LUNESTA was approved as eszopiclone by TEVA on May 23rd, 2011.
Summary for LUNESTA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 60 |
Clinical Trials: | 45 |
Patent Applications: | 3,637 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LUNESTA |
What excipients (inactive ingredients) are in LUNESTA? | LUNESTA excipients list |
DailyMed Link: | LUNESTA at DailyMed |
Recent Clinical Trials for LUNESTA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Laboratorios Andromaco S.A. | Phase 1 |
University of California, San Diego | Phase 2 |
VA Office of Research and Development | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for LUNESTA
Paragraph IV (Patent) Challenges for LUNESTA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LUNESTA | Tablets | eszopiclone | 1 mg, 2 mg and 3 mg | 021476 | 10 | 2008-12-15 |
US Patents and Regulatory Information for LUNESTA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-001 | Dec 15, 2004 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-002 | Dec 15, 2004 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-003 | Dec 15, 2004 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LUNESTA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-003 | Dec 15, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-002 | Dec 15, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-001 | Dec 15, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-001 | Dec 15, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-001 | Dec 15, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-002 | Dec 15, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-002 | Dec 15, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LUNESTA
See the table below for patents covering LUNESTA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Yugoslavia | 48878 | ⤷ Try a Trial | |
Hungary | 218928 | Optikailag aktív zopiclone, eljárás előállítására és az ezt tartalmazó gyógyszerkészítmény (OPTICALLY ACTIVE ZOPICLONE, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME) | ⤷ Try a Trial |
Finland | 100331 | ⤷ Try a Trial | |
European Patent Office | 0495717 | ⤷ Try a Trial | |
Philippines | 30982 | Optically active 5H-pyrrolo Ä3,4-bÜ pyrazine derivative, its preparation and pharmaceutical compositions containing it. | ⤷ Try a Trial |
Australia | 671797 | ⤷ Try a Trial | |
Norway | 179911 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |